Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Two-year effects of semaglutide in adults with overweight or obesity (STEP-5)
Konitzer, T
GIP/GLP-1/glucagon (GCG) triple agonists represent a particularly exciting new drug class that is being studied in patients with obesity
These infections, characterized by a range of uncomfortable symptoms, can impact anyone but are notably more common in certain populations
Students, healthcare workers, teachers, and others in demanding positions may benefit from lower-dose approaches that prioritize predictability
US$ 28.55
US$ 20.18
US$ 24.51
US$ 20.32
US$ 29.85
US$ 25.19
US$ 23.16
US$ 29.55
US$ 28.62
US$ 28.04
